Latest Articles
News
August 2021
August 2021
Phenotypeca raises an additional £450,000 seed investment and further enhances its Board.
News
July 2021
July 2021
Expansion of Phenotypeca’s Yeast Biofoundry with a mission to make medicines more affordable and accessible to all that need them.
Team
July 2021
July 2021
Phenotypeca expands team with the appointment of Dr Emanuele Kendrick at its facilities at the University of Nottingham
News
February 2021
February 2021
IN THE NEWS - Vax-Hub’s February Newsletter featuring Phenotypeca® focuses on academic-industry partnerships and vaccine technology
News
January 2021
January 2021
PRESS RELEASE: Nottingham start-up develops novel baker’s yeast for the low-cost manufacture of therapeutic proteins, vaccines and diagnostics.
Team
December 2020
December 2020
Phenotypeca Ltd expands its Board of Directors, welcoming Simon Chalk as their new Non-Executive Director
Funding
November 2020
November 2020
Phenotypeca win Feasibility Study funding from the Future Vaccine Manufacturing Research Hub (Vax-Hub) in partnership with The Jenner Institute
Team
October 2020
October 2020
Phenotypeca welcome molecular biology specialist, Dr Cindy Vallières, to their research team
Team
September 2020
September 2020
Phenotypeca is honoured to appoint Patrick Florent as non-Executive Chairman of the Board
Team
August 2020
August 2020
Phenotypeca engages grant writing specialist, Dr Emma Richardson, to lead a non-dilutive funding strategy at the end of August
Team
May 2020
May 2020
Phenotypeca is delighted to appoint Dr David Harvey to help deliver on our research projects
News
March 2020
March 2020
Phenotypeca successfully complete first quarter of Innovate UK Project with Invizius and CPI
Team
January 2020
January 2020
Phenotypeca is delighted to have employed Dr Anne Henstra to help deliver the IUK project won in December over the next 16 months.
Funding
December 2019
December 2019
Phenotypeca wins £373,000 Innovate UK SMART Grant to develop second generation S. cerevisiae hosts for enhanced protein yield and quality
Team
November 2019
November 2019
Phenotypeca is delighted to appoint Patrick Florent from GSK Vaccines and patent attorney Anton Hutter to our Advisory Board
Research
October 2019
October 2019
Phenotypeca commences a second R&D project using baker’s yeast in their synthetic biology platform
Research
September 2019
September 2019
Phenotypeca to start research in the Synthetic Biology Research Centre at the University of Nottingham’s Biodiscovery Institute
Team
June 2019
June 2019
Phenotypeca is delighted to engage the services of Professor Ed Louis to lead their genomics programme
Navigation
Office Address
Phenotypeca Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF.
Email: info@phenotypeca.com
Research Address
University of Nottingham's Synthetic Biology Research Centre in the Biodiscovery Institute, University of Nottingham, University Boulevard, Nottingham, United Kingdom, NG7 2RD
© Copyright 2021 Phenotypeca Ltd. All Rights Reserved. Phenotypeca Ltd is a limited company incorporated in England with registered number 11700555.
Terms and Conditions | Privacy Policy
Website built by IvyJack Communications Ltd